PREZCOBIX: payments to doctors
Payments that named PREZCOBIX as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $197K
- Providers
- 1,129
- Transactions
- 4,887
- Average per transaction
- $40
The per-transaction average — $40 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,129 providers the average total is $174, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $85,655 | 43.5% |
| Janssen Scientific Affairs, LLC | $79,603 | 40.4% |
| Janssen Products, LP | $31,667 | 16.1% |
| Biosense Webster, Inc. | $10 | 0.0% |